Related Experiment Video
Updated: Jan 21, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Neonatal ibuprofen exposure and bronchopulmonary dysplasia in extremely premature infants
Xueyu Chen1, Xiaomei Qiu1, Panpan Sun1
1Department of Neonatology, Affiliated Shenzhen Maternity & Child Healthcare Hospital, Southern Medical University, Shenzhen, China.
Insights
Early ibuprofen exposure in extremely premature infants was linked to a higher risk of bronchopulmonary dysplasia (BPD). This suggests ibuprofen may contribute to BPD development in these vulnerable infants.
Area of Science:
- Neonatalogy
- Pediatric Pulmonology
- Pharmacology
Background:
- Bronchopulmonary dysplasia (BPD) is a significant complication in extremely premature infants.
- The role of early pharmacological interventions, such as ibuprofen, in BPD development requires further investigation.
Purpose of the Study:
- To evaluate the association between early ibuprofen exposure and the risk of developing bronchopulmonary dysplasia (BPD) in extremely premature infants.
Main Methods:
- Retrospective study design.
- Inclusion of 203 extremely premature infants admitted to a tertiary unit between 2016 and 2018.
- Statistical analysis comparing BPD rates between infants with and without early ibuprofen exposure, adjusting for covariates.
Main Results:
- The rate of BPD was significantly higher in infants with early ibuprofen exposure (42.5%) compared to those without exposure (21.6%, P=0.001).
- Ibuprofen exposure was independently associated with an increased risk of BPD (OR 2.296, 95% CI: 1.166-4.522, p=0.016).
- A trend towards higher BPD risk was observed in infants with successful patent ductus arteriosus (PDA) closure after ibuprofen treatment compared to non-treated infants (32.3% vs 20.2%, p=0.162).
Conclusions:
- Ibuprofen exposure may be a contributing factor to the development of BPD in extremely preterm infants.
- Further research is warranted to elucidate the specific mechanisms and clinical implications.
Objective:
To evaluate the association of ibuprofen exposure with the risk of bronchopulmonary dysplasia (BPD) in extremely premature infants.
Study Design:
This was a retrospective study of all extremely premature infants admitted to a tertiary unit from 2016 to 2018.
Results:
A total of 203 extremely premature infants were included in this study. The rate of BPD was significantly higher in infants with early exposure to ibuprofen (42.5%) compared to infants with no exposure (21.6%, P = 0.001). After adjusting for covariates, the risk of BPD was associated independently with ibuprofen exposure (odds ratios (OR) 2.296, 95% confidence interval (CI): 1.166-4.522, p = 0.016). Further analysis showed a trend towards higher risk of BPD in infants with successful patent ductus arteriosus (PDA) closure after ibuprofen treatment (32.3%) compared to non-treated infants (20.2%, p = 0.162).
Conclusion:
Our findings suggest that ibuprofen exposure may contribute to the occurrence of BPD in extremely preterm infants.
More Related Videos
Related Concept Videos
Absolute and Local Extreme Values
Drug Dosing: Infants and Children
Theory of Romantic Attachment in Adulthood
Mutations
Improving Translational Accuracy
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

